This is why I had to quit working in 2020. A mask forces you to rebreathe your own exhaled carbon dioxide, which can cause your oxygen saturation levels to drop to dangerous levels. It's called hypercarbia or hypercapnia. The moment I put a mask on, my oxygen saturation levels DROP below 85%. Any level BELOW 90% can put you into Cardiac Arrest. This so-called doctor doesn't understand that unless you suffer from respiratory or cardiology issues, chances are that you won't suffer any distress, but if you have COPD, asthma, any other respiratory illness or heart issues, your chances are quite high. Obese people are also at risk. That's the science. Anything less than 90% can put me into cardiac arrest. If you suffer from any of the above illnesses, you are putting yourself at risk if you follow Mask Mandates. DO NOT COMPLY!

(admin) Its on Russel Brand but here it is anyway: How Pfizer Bribes Led to Vaccine Mandates https://rumble.com/v2k5xy0-exclusive-report-holy-sht-pfizer-secretly-funded-who-114-stay-free-with-rus.html Story at-a-glance In 2022, Pfizer became the first drug company in history to break $100 billion in annual sales. That year, Pfizer spent $2.8 billion on ads, an increase of $800 million from 2021 But Pfizer’s success isn’t due to direct ads. It’s because a) the U.S. government spent $1 billion of taxpayers’ money to promote the experimental COVID jab, and b) Pfizer paid millions to consumer, medical and civil rights groups that lobbied for COVID jab mandates on Pfizer’s behalf Special interest groups paid by Pfizer to push for COVID jab mandates and coercive vaccine policies include the Chicago Urban league (which argued that the jab mandate would benefit the Black community), the National Consumers League, the Immunization Partnership, the Advertising Council and a long list of universities and cancer, liver diseases, cardiology, rheumatology and medical science organizations April 19, 2023, the U.S. Centers for Disease Control and Prevention revised its COVID jab guidance. The original monovalent mRNA shots are no longer recommended for use in the U.S. Instead, the CDC recommends people 6 years old and older get an updated bivalent mRNA COVID shot, even if they’ve not completed the monovalent series While the World Health Organization seems to be backing off from endless COVID boosters for all, there’s clear evidence that mRNA gene therapy is here to stay. mRNA “vaccines” are in the works for influenza, respiratory syncytial virus (RSV), shingles, genital herpes and cancer, just to name a few https://articles.mercola.com/sites/articles/archive/2023/05/02/how-pfizer-bribes-led-to-vaccine-mandates.aspx?ui=551eda515442ee5cc8f0c77cc67b3f3febd63142ec0dc6cef1d4521e5ea666eb&sd=20200307&cid_source=dnl&cid_medium=email&cid_content=art1ReadMore&cid=20230502&cid=DM1392193&bid=1789126525

https://rumble.com/v1zs40e-watch-pediatric-cardiologist-gives-emotional-testimony-on-what-the-covid-va.html Pediatric Cardiologist Gives Emotional Testimony on What the COVID Vax Does to Young Hearts. #cardiology #covid #vax #vaccines #children

Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning A Peer Reviewed Journal BTW Doctor Vernon Coleman says that THIS STUDY being released shows that the #mRNA #Vaccine is a KILLER and anyone still injecting it into people is a #Murderer! Abstract Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS). The score is based on changes from the norm of multiple protein biomarkers including IL-16, a proinflammatory cytokine, soluble Fas, an inducer of apoptosis, and Hepatocyte Growth Factor (HGF)which serves as a marker for chemotaxis of T-cells into epithelium and cardiac tissue, among other markers. Elevation above the norm increases the PULS score, while decreases below the norm lowers the PULS score.The score has been measured every 3-6 months in our patient population for 8 years. Recently, with the advent of the mRNA COVID 19 vaccines (vac) by Moderna and Pfizer, dramatic changes in the PULS score became apparent in most patients.This report summarizes those results. A total of 566 pts, aged 28 to 97, M:F ratio 1:1 seen in a preventive cardiology practice had a new PULS test drawn from 2 to 10 weeks following the 2nd COVID shot and was compared to the previous PULS score drawn 3 to 5 months previously pre- shot. Baseline IL-16 increased from 35=/-20 above the norm to 82 =/- 75 above the norm post-vac; sFas increased from 22+/- 15 above the norm to 46=/-24 above the norm post-vac; HGF increased from 42+/-12 above the norm to 86+/-31 above the norm post-vac. These changes resulted in an increase of the PULS score from 11% 5 yr ACS risk to 25% 5 yr ACS risk. At the time of this report, these changes persist for at least 2.5 months post second dose of vac.We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination. https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712

https://www.vaticannews.va/en/vatican-city/news/2021-10/st-peter-s-square-hosts-cardiology-mobile-clinic-for-poor.html

The global wound closure market is set to gain impetus from the ever-increasing inclination of people from traditional suturing techniques to innovative devices, namely, hemostatic agents, clips, and staplers. It is mainly occurring in countries such as India, China, Japan, Germany, and the U.S. Fortune Business Insights™ provided this information in a recent report, titled, “Wound Closure Market Size, Share & Industry Analysis, By Product Type (Sutures, Hemostatic Agents, Staplers, Staples, and Others), By Application (Gynaecology, Cardiology, Orthopedics, Ophthalmic, General Surgery, and Others), By End User (Hospitals and Ambulatory Surgical Centers, Specialty Clinics, and Others), and Regional Forecast, 2019-2026.” For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/wound-closure-market-102630

The global wound closure market is set to gain impetus from the ever-increasing inclination of people from traditional suturing techniques to innovative devices, namely, hemostatic agents, clips, and staplers. It is mainly occurring in countries such as India, China, Japan, Germany, and the U.S. Fortune Business Insights™ provided this information in a recent report, titled, “Wound Closure Market Size, Share & Industry Analysis, By Product Type (Sutures, Hemostatic Agents, Staplers, Staples, and Others), By Application (Gynaecology, Cardiology, Orthopedics, Ophthalmic, General Surgery, and Others), By End User (Hospitals and Ambulatory Surgical Centers, Specialty Clinics, and Others), and Regional Forecast, 2019-2026.” The report further mentions that the wound closure market size was USD 13.24 billion in 2018 and is projected to reach USD 21.03 billion by 2026, exhibiting a CAGR of 6.0% during the forecast period. For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/wound-closure-market-102630

Dr. Jane Ruby is a licensed nurse practitioner, internal medicine, subspecialty surgical and medical cardiology. https://rumble.com/vk71s6-novavax-safe-alternative-to-pfizer-moderna-expert-reveals-dark-reality..html